The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 20, 2019
The FDA announced the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus, caused by Zaire ebolavirus in individuals ...
read more
Friday, December 20, 2019
Quantum Genomics announced the initiation of its pivotal Phase III FRESH study in difficult-to-treat1 and resistant2 hypertension.
read more
Thursday, December 19, 2019
VistaGen and Baylor announced successful results from a clinical study with healthy U.S. military Veterans, which measured NMDAR target engagement of ...
read more
Tuesday, December 17, 2019
Aequus announced the signing of a term sheet to co-commercialize products in the US with Medicom Healthcare.
read more
Monday, December 16, 2019
Avenue Therapeutics has submitted a NDA to the FDA for IV tramadol for moderate to moderately severe pain in adults in a medically supervised health ...
read more
Monday, December 16, 2019
Soligenix has opened the study titled "A Phase 1C, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety of RiVax®, a Lyophilized ...
read more
Friday, December 13, 2019
Janssen Research & Development
Janssen announced OS results from the ALCYONE study, which showed the addition of DARZALEX to bortezomib, melphalan and prednisone improved OS in ...
read more
Friday, December 13, 2019
Navigen announced the FDA has cleared its IND for the initiation of a Phase I study in healthy volunteers to test the safety, tolerability, and ...
read more
Friday, December 13, 2019
GIOSTAR announced they are in the process of approval from the FDA to conduct type 2 diabetes clinical trials focused on development of stem cell-...
read more
Thursday, December 12, 2019
Fate Therapeutics announced initial clinical data for its FT516 and FT500 off-the-shelf, iPSC-derived natural killer (NK) cell product candidates.
read more
Thursday, December 12, 2019
Alkahest presented data this weekend from its phase 2a study, AKST6019-201, in mild-to-moderate Alzheimer’s Disease.
read more
Tuesday, December 10, 2019
Trovagene announced new in-vitro and in-vivo data suggesting that onvansertib may provide a new therapeutic option for patients who develop resistance...
read more
Monday, December 09, 2019
Lannett has announced positive results from the first human study evaluating insulin glargine.
read more
Friday, December 06, 2019
CenExel Clinical Research has announced the acquisition of Research Centers of America (RCA) in Hollywood, FL.
read more
Friday, December 06, 2019
The FDA has approved three applications for first generics of Gilenya capsules for the treatment of relapsing forms of multiple sclerosis in adult ...
read more